Atreca Presents Initial Clinical Data from Phase 1b Trial of ATRC-101 in Select Advanced Solid Tumors

Source :: Legal Monitor Worldwide. July 30, 2021
Publication Year :: 2021
Abstract: (GlobeNewswire) - Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune [...]

Subjects :: Medical research
Medicine, Experimental
Tumors -- Research
Clinical trials -- Research
Business, international
Law

Tools